| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2019/04/16 | 05:32 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/04/13 | 02:01 | PR Newswire (US) | Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory a... | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/04/11 | 05:45 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/04/11 | 05:35 | GlobeNewswire Inc. | Vital Therapies, Inc. Announces Filing of its Form 10-Q for the Quarter Ended March 31, 2019 | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/04/11 | 05:19 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/04/05 | 05:07 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/04/05 | 05:07 | GlobeNewswire Inc. | Vital Therapies, Inc. Announces Stockholder Approval of Business Combination with Immunic AG | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/04/03 | 05:20 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/03/28 | 05:08 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/03/27 | 19:00 | GlobeNewswire Inc. | Vital Therapies Reminds Stockholders to Vote For the Proposed Business Combination With Immunic AG | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/03/26 | 05:07 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/03/25 | 18:00 | GlobeNewswire Inc. | Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Vital Therapies Stockholders Vote “FOR” the Prop... | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/03/23 | 05:09 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/03/20 | 06:20 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/03/15 | 05:04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/03/14 | 05:01 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/03/05 | 07:17 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/03/05 | 06:23 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/03/05 | 06:10 | GlobeNewswire Inc. | Vital Therapies Announces 2018 Financial Results | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/03/01 | 06:21 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/02/27 | 06:18 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/02/20 | 07:05 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/02/15 | 20:33 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/02/14 | 23:04 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/02/07 | 06:37 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/02/05 | 08:01 | Edgar (US Regulatory) | Securities Registration: Business Combination (s-4) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/02/02 | 05:39 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/01/25 | 07:07 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/01/15 | 06:53 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |
| 2019/01/08 | 06:43 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VTL | Vital Therapies, Inc. (MM) |